http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2752191-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6559372bde7c7c71d22286457328c86 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| filingDate | 2013-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76681c06a335bb484e36858064b68f63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8807404b12f5804c61ba6d98281c143c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ddd33bcfc2c99e2365c940bddabbc9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e586d41de57cdcecdd621d4ff6a9c5b |
| publicationDate | 2020-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2752191-T3 |
| titleOfInvention | Compositions and methods with AAV vectors for gene transfer to cells, organs and tissues |
| abstract | A composition for use in a method of treating a bleeding disorder in a mammal, wherein the composition comprises an adeno-associated virus (AAV) vector comprising a VP1, VP2 and VP3 sequence of AAV-Rh74 set forth in SEQ ID NO. : 1, 3 and 4, respectively, as shown in Figure 3, and said vector further comprises a heterologous polynucleotide sequence comprising a gene encoding a blood coagulation (clot-forming) factor, wherein the polynucleotide sequence heterologous is operably linked to an expression control element that confers transcription of said heterologous polynucleotide sequence, wherein the expression control element is a promoter active in the liver, and wherein the method comprises administering the adeno-associated virus (AAV) vector to said mammal, whereby the heterologous polynucleotide sequence is administered or transferred to the mammal. |
| priorityDate | 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1720.